GO
Loading...

Stop Trading!: Amgen's Attractive

Cramer called Amgen a "limited risk, very big reward play" today on Stop Trading!.

Amgen is involved in a lawsuit with Roche that could see the inside of a courtroom this month or next, and Cramer said he thinks Amgen could win.

"This Roche lawsuit, if it goes their way, you're going to do very well with this stock," he said.

Cramer said he thinks the risk-reward ratio was three points of downside to seven points of upside, if Amgen wins the suit.

Celgene is still his favorite pharmaceuticals play, though.

Also, Cramer said that Deere has become a momentum stock whose share price should keep going up.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book